IMCD schedules November 5 results. IMCD stock sits 4.97 percent below its high

Published on 10/21/2026 at 10:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

IMCD sets November 5, 2026 for nine-month results. IMCD stock costs EUR 100.30 on October 21, 2026, 4.97 percent below its 52-week high.

Cash conversion and reporting dates

IMCD will publish first nine months results on November 5, 2026.
Operating EBITA reached EUR 285 million in the first half of 2026, up 8 percent on a constant currency basis.
IMCD stock trades at EUR 100.30 at 10:51 a.m. CEST at Lang & Schwarz on October 21, 2026.
Free cash flow reached EUR 222 million in the first half of 2026.
Market capitalization stood at EUR 5.9 billion as of October 21, 2026.

Editorial-Foto eines Handelsraums mit Börsenbildschirmen zu Euronext Amsterdam und AEX 25 — Börsen-Editorial zeigt Handelsraum mit Euronext Amsterdam Charts, Notierung von IMCD N.V., ISIN NL0010801007, Illustration mit AI erstellt.

IMCD N.V. (ISIN NL0010801007) was trading at EUR 100.30 at Lang & Schwarz on October 21, 2026 at 10:51 a.m. CEST, 4.97 percent below its 52-week high of EUR 105.55. GlobeNewswire reported on October 15, 2026 that IMCD will publish its first nine months results on November 5, 2026. The date gives the stock a clear near-term reporting marker.

Three milestones shape the setup

IMCD reported operating EBITA of EUR 285 million for the first half of 2026, up 8 percent on a constant currency basis, in its July 29 results call. Free cash flow reached EUR 222 million, while cash conversion was 76.2 percent. These figures show why the coming report will be judged on both profit growth and cash generation, not revenue alone.

In chronological order, IMCD reported operating EBITA of EUR 285 million on July 29, 2026; it showcased three new formulations at the SEPAWA event on October 7, 2026; and it set November 5, 2026 as the publication date for its first nine months results on October 15, 2026. The sequence links operating delivery with commercial activity and the next quantified checkpoint.

What will the next report test?

The main test is whether the first-half improvement can continue across the business. In the results call, management said second-quarter organic gross profit growth reached 7 percent after a weaker first quarter, while the gross profit margin was 24.9 percent for the first half. Yahoo Finance also reported that IMCD had about 5,200 full-time employees and made three acquisitions during the first half.

Upcoming dates for investors

The next substantiated dates are November 5, 2026, for publication of the first nine months results, and February 19, 2027, for publication of the full year 2026 results. The company lists both dates on its investor-relations page, alongside fiscal year 2025 revenue of EUR 4,778.9 million and free cash flow of EUR 465.2 million, which provide historical comparison points for the next update.

Valuation meets execution

IMCD's market capitalization was EUR 5.9 billion as of October 21, 2026, while its 52-week range was EUR 68.14 to EUR 105.55. The current quote is therefore close to the upper end of its annual range, leaving execution on margins, cash conversion and acquisition integration as the practical measures for the November report. The stock's specialty-chemicals distribution model remains tied to supplier relationships, formulation expertise and expansion across international markets.

IMCD stock was trading at EUR 100.30 at Lang & Schwarz on October 21, 2026 at 10:51 a.m. CEST, with the 52-week high at EUR 105.55. The further course of trading is shown by the continuously updated real-time quote of IMCD stock.